Engesæter, B., Engebraaten, O., Flørenes, V. A., & Mælandsmo, G. M. (2012). Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. Public Library of Science.
Styl ChicagoEngesæter, Birgit, Olav Engebraaten, Vivi Ann Flørenes, a Gunhild Mari Mælandsmo. Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. Public Library of Science, 2012.
Citace podle MLAEngesæter, Birgit, Olav Engebraaten, Vivi Ann Flørenes, a Gunhild Mari Mælandsmo. Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma. Public Library of Science, 2012.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..